Vaccine News and Research

Latest Vaccine News and Research

Global climate change to increase vulnerability to HIV/AIDS of people in developing countries

Climate change is the newest threat to the increasing HIV/AIDS epidemic worldwide, panelists said Wednesday at an HIV forum at the University of New South Wales in Sydney, Australia, the AAP/Age reports (McLean, AAP/Age, 4/30).

30 Apr 2008

Young children hospitalized for flu associated with higher costs and higher risk illness

The high costs of hospitalizing young children for influenza creates a significant economic burden in the United States, underscoring the importance of preventive flu shots for children and the people with whom they have regular contact, according to research led by Cincinnati Children's Hospital Medical Center and presented May 4 at the Pediatric Academic Society annual meeting in Honolulu, Hawaii.

30 Apr 2008

Mothers less likely to pursue HPV vaccination for youngest daughters

Because the first national study of its kind has found that U.S. mothers report they are less likely to vaccinate daughters under age 13 against human papillomavirus virus (HPV), even though the vaccine is recommended for girls at age 11 and 12, it's incumbent upon the healthcare community to work to improve moms' acceptance of the vaccination for younger daughters, say researchers at Cincinnati Children's Hospital Medical Center who conducted the study. HPV is a sexually transmitted virus known to cause cervical cancer.

30 Apr 2008

Climate change could increase HIV infection rates world-wide

Social factors, including economic pressures caused by climate change, could lead to an increase in HIV infection rates world-wide, warns a leading researcher from the University of New South Wales (UNSW).

30 Apr 2008

ImmunoVaccine Technologies patents DepoVax vaccine platform

ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, unveiled today its DepoVax platform, a novel depot vaccine delivery system used to increase the efficacy and strength of vaccines. IVT has filed additional patents to protect the DepoVax concept.

30 Apr 2008

Discovery of quick method for making human monoclonal antibodies against flu

Human monoclonal antibodies (mAbs) - highly specific, identical, infection-fighting proteins produced in large quantities in the lab in cell lines that are derived from a single antibody-producing cell - against influenza can be rapidly produced in the lab, according to a new report from scientists supported by the National Institutes of Health (NIH).

30 Apr 2008

Scientists determine drug target for the most potent botulinum neurotoxin

Botulinum neurotoxin - responsible for the deadly food poisoning disease botulism and for the beneficial effects of smoothing out facial wrinkles - can also be used as a dreaded biological weapon. When ingested or inhaled, less than a billionth of an ounce can cause muscle paralysis and eventual death. Although experimental vaccines administered prior to exposure can inhibit the destructive action of this neurotoxin - the most deadly protein known to humans - no effective pharmacological treatment exists.

29 Apr 2008

CDC says one in four children are out of compliance with U.S. vaccination guidelines

Your toddler might be improperly vaccinated, even if she's had every immunization the government recommends, according to a new study from the Centers for Disease Control and Prevention.

29 Apr 2008

Enterovirus 71 in Chinese province kills 20 children

A virus in China has which has killed 20 children and made 1,179 others ill is causing alarm.

29 Apr 2008

U.S., British HIV/AIDS researchers pessimistic about prospects of vaccine, survey finds

Leading HIV/AIDS researchers in Britain and the U.S. are pessimistic about the prospects of developing an HIV vaccine following the recent failure of a Merck vaccine candidate, according to a survey conducted by London's Independent, the Independent reports (Connor/Green, Independent, 4/24).

26 Apr 2008

Yellow Fever.update in Liberia

The Ministry of Health, Liberia has reported one additional confirmed case of Yellow fever. The case, a 30 year old man, is from the same community as the index case, Zuotuo, Tappita District. Nimba County.

26 Apr 2008

DNA vaccines may offer hope in multiple sclerosis

Authors from the VA North Texas Health Care System Neurology Section and the Department of Neurology at the University of Texas Southwestern Medical Center at Dallas have highlighted the potential benefits for DNA-based vaccine administration in patients with multiple sclerosis (MS).

24 Apr 2008

Protein HtpG signals healthier teeth and gums

Antibodies present in people with good oral health could become the first tool for dental professionals to assess a patient's probable response to periodontal disease treatments, say researchers at the University of Michigan.

23 Apr 2008

FSU research may speed new malaria treatments, vaccines for children

April 25 is World Malaria Day 2008 and despite the grim statistics out of Africa there's cause for celebration. Florida State University biologists have discovered an autoimmune-like response in blood drawn from malaria-infected African children that helps to explain why existing DNA-based anti-malaria vaccines have repeatedly failed to protect them.

23 Apr 2008

Simplified economical method of giving rabies vaccine

A simplified economical method of giving rabies vaccine is just as effective as the expensive standard vaccine regimen at stimulating anti-rabies antibodies.

23 Apr 2008

NIAID tackles drug-resistant tuberculosis

Tuberculosis (TB) has long been one of the world’s great killers. Now, forms of drug-resistant TB--multidrug (MDR) and extensively drug-resistant (XDR)--are occurring at an ominous and accelerating rate. To help in the fight against drug-resistant TB, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has formulated an MDR and XDR TB research agenda.

22 Apr 2008

Commitment to conducting more basic research in search for HIV/AIDS vaccine 'prudent,' editorial says

The cancellation last fall of a Merck HIV/AIDS vaccine trial was "branded as a 'catastrophe' by one scientist and as setting the race for a cure 'back to square one' by others," a Washington Post editorial says, adding, "The hyperbole is understandable, but some perspective is in order."

21 Apr 2008

European action in global life sciences - food forum

The EAGLES conference focused on the European response through research to the global challenges posed by food security, quality and safety, and sustainable agriculture in the developing and emerging countries (DECs).

21 Apr 2008

Queensland Health and Cancer Council in fight over access to cancer data

Queensland Health Minister Stephen Robertson is again embroiled in yet another crisis which will leave Queenslanders doubting his ability to deal with the job.

20 Apr 2008

Purdue's new vaccine under development may provide protection against highly pathogenic bird flu

A new vaccine under development may provide protection against highly pathogenic bird flu and its evolving forms, according to researchers at Purdue University and the Centers for Disease Control and Prevention who discovered the new preventative drug and have tested it in mice.

17 Apr 2008